• Directory of Taiwan

Zika Virus Vaccines Market Estimated To Skyrocket in the Forecast Period 2021-2030

Zika virus is transmitted through Aedes mosquito bite, which can also transmit chikungunya, dengue, and yellow fever. The other modes of transmission of Zika virus is through sex and from an infected mother to the fetus. The onset of Zika virus is yet not clear. The symptoms are similar to that of dengue, including fever, skin rashes, joint pain, and headache, which are mild and last for two to seven days.

The Zika virus vaccines market is estimated to generate $14,500 million in 2017, and is expected to reach $18,697 million by 2022, growing at a CAGR of 5.2%. The market has high potential owing to increase in demand for vaccines for immunization and further prevention in regions such as Latin America and Central America.

Request To Download Sample of This Strategic Report:-

Market Statistics:

The file offers market sizing and forecast throughout 5 primary currencies – USD, EUR GBP, JPY, and AUD. It helps corporation leaders make higher choices when foreign money change records are available with ease. In this report, the years 2020 and 2021 are regarded as historic years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2030 are viewed as the forecast period.

The Centers for Medicare and Medicaid Services report that US healthcare expenditures grew by 4.6% to US$ 3.8 trillion in 2019, or US$ 11,582 per person, and accounted for 17.7% of GDP. Also, the federal government accounted for 29.0% of the total health expenditures, followed by households (28.4%). State and local governments accounted for 16.1% of total health care expenditures, while other private revenues accounted for 7.5%.

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

According to WHO, approximately 1.6 million individuals are infected with Zika virus, and the number is exponentially increasing. In addition, surgical demand for vaccines that can cure Zika-linked birth defects has increased.

Get a Request Sample Report:

Zika virus disease is caused by mosquitoes that belongs to Flavivirus genus, and was first identified in Uganda in 1947 in monkeys. It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania. Major outbreak of the disease was reported in 2007 in the Yap Island. In addition, an association between Zika virus infection and Guillain-Barre syndrome was reported in July 2015 in Brazil, and later in October 2015, Brazil reported an association between Zika virus infection and microcephaly.

The global Zika virus vaccine market is segmented based on forecast scenario analysis and geography. On the basis of forecast scenario analysis, the market is categorized into rapid growth, moderate growth, and low growth. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.


In-depth study of the global Zika virus vaccines market was conducted based on the current disease prevalence, target population, and pricing to generate market size & forecast from 2017 to 2022.
Potential analysis of opportunities was evaluated to understand different aspects of Zika virus vaccines that are currently clinical trials along with the variants that are expected to gain prominence in the future.
Key market players are profiled and their strategies are analyzed thoroughly to understand the various technologies adopted by them to manufacture Zika virus vaccines.


By Forecast Scenario Analysis

Rapid Growth Scenario
Moderate Growth Scenario
Low Growth Scenario

By Region

North America

Request full Report-

By Country

Rest of the World


Immunovaccine Inc.
Takeda Pharmaceutical Co. Ltd.
Bharat Biotech International Ltd.
NewLink Genetics Co.
Inovio Pharmaceuticals, Inc.
GeneOne Life Science Inc.
GlaxoSmithKline Plc.
Sanofi S.A.
Hawaii Biotech Inc.

Table of Content:

  • Market Definition and Overview
  • Research Method and Logic
  • Market Competition Analysis
  • Product and Service Analysis
  • Strategies for Company to Deal with the Impact of COVID-19
  • Market Segment by Type, Historical Data and Market Forecasts
  • Market Segment by Application, Historical Data and Market Forecasts
  • Market by by Region, Historical Data and Market Forecasts
  • Market Dynamic Analysis and Development Suggestions

Key Questions Answered in the Market Report

• How did the COVID-19 pandemic impact the adoption of by various pharmaceutical and life sciences companies?
• What is the outlook for the impact market during the forecast period 2021-2030?
• What are the key trends influencing the impact market? How will they influence the market in short-, mid-, and long-term duration?
• What is the end user perception toward?
• How is the patent landscape for pharmaceutical quality? Which country/cluster witnessed the highest patent filing from January 2014-June 2021?
• What are the key factors impacting the impact market? What will be their impact in short-, mid-, and long-term duration?
• What are the key opportunities areas in the impact market? What is their potential in short-, mid-, and long-term duration?
• What are the key strategies adopted by companies in the impact market?
• What are the key application areas of the impact market? Which application is expected to hold the highest growth potential during the forecast period 2021-2030?
• What is the preferred deployment model for the impact? What is the growth potential of various deployment models present in the market?
• Who are the key end users of pharmaceutical quality? What is their respective share in the impact market?
• Which regional market is expected to hold the highest growth potential in the impact market during the forecast period 2021-2030?
• Which are the key players in the impact market?

Inquire or Share Your Questions If Any Before the Purchasing This Report –

About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)